Neuromuscular Morphology Unit, Myology Institute, Groupe Hospitalier Universitaire La Pitié-Salpêtrière, Paris, France Inserm, U974, Paris, France University Pierre et Marie Curie- Paris 6, UM 76, CNRS, UMR 7215, Myology Institute, IFR14, Paris, France Centre de référence de Pathologie Neuromusculaire Paris-Est, Institut de Myologie, GHU La Pitié-Salpêtrière, Assistance Publique-Hôpitaux de Paris, Paris, France.
Department of Translational Medicine and Neurogenetics, IGBMC, Illkirch, France Inserm, U964, Illkirch, France CNRS, UMR7104, Illkirch, France Université de Strasbourg, Illkirch, France Collège de France, chaire de génétique humaine, Illkirch, France.
J Neurol Neurosurg Psychiatry. 2014 Oct;85(10):1149-52. doi: 10.1136/jnnp-2013-306754. Epub 2014 May 14.
Autosomal dominant (AD) central core disease (CCD) is a congenital myopathy characterised by the presence of cores in the muscle fibres which correspond to broad areas of myofibrils disorganisation, Z-line streaming and lack of mitochondria. Heterozygous mutations in the RYR1 gene were observed in the large majority of AD-CCD families; however, this gene was excluded in some of AD-CCD families.
To enlarge the genetic spectrum of AD-CCD demonstrating mutations in an additional gene.
Four affected AD family members over three generations, three of whom were alive and participate in the study: the mother and two of three siblings. The symptoms began during the early childhood with mild delayed motor development. Later they developed mainly tibialis anterior weakness, hypertrophy of calves and significant weakness (amyotrophic) of quadriceps. No cardiac or ocular involvement was noted.
The muscle biopsies sections showed a particular pattern: eccentric cores in type 1 fibres, associated with type 1 predominance. Most cores have abrupt borders. Electron microscopy confirmed the presence of both unstructured and structured cores. Exome sequencing analysis identified a novel heterozygous missense mutation p.Leu1723Pro in MYH7 segregating with the disease and affecting a conserved residue in the myosin tail domain.
We describe MYH7 as an additional causative gene for AD-CCD. These findings have important implications for diagnosis and future investigations of AD-congenital myopathies with cores, without cardiomyopathy, but presenting a particular involvement of distal and quadriceps muscles.
常染色体显性(AD)中央核心病(CCD)是一种先天性肌病,其特征是肌肉纤维中有核心,对应于肌原纤维广泛区域的紊乱、Z 线流和线粒体缺失。在大多数 AD-CCD 家族中观察到 RYR1 基因的杂合突变;然而,在一些 AD-CCD 家族中排除了该基因。
扩大 AD-CCD 的遗传谱,证明在另一个基因中存在突变。
三代中有四个受影响的 AD 家族成员,其中三个在世并参与了研究:母亲和三个兄弟姐妹中的两个。症状在幼儿期开始出现,表现为轻度运动发育迟缓。后来,他们主要发展为胫骨前肌无力、小腿肥大和明显的(进行性)股四头肌无力。未发现心脏或眼部受累。
肌肉活检切片显示出一种特殊的模式:1 型纤维中的偏心核心,与 1 型纤维优势相关。大多数核心具有突然的边界。电子显微镜证实存在无结构和结构核心。外显子组测序分析发现了一种新的杂合错义突变 p.Leu1723Pro,在 MYH7 中与疾病分离,并影响肌球蛋白尾部结构域中的保守残基。
我们将 MYH7 描述为 AD-CCD 的另一个致病基因。这些发现对无心肌病、但表现出远端和股四头肌特殊受累的伴有核心的 AD-先天性肌病的诊断和未来研究具有重要意义。